May 28, 2015
Scientists from the Multidisciplinary Association for Psychedelic Studies (MAPS) are hoping to help 18 terminally ill patients relieve their anxiety, depression, and fear in the next year during extended psychotherapy sessions enhanced by MDMA (ecstasy). The Marin County-based double-blind trial will see subjects test either full doses of MDMA (125 milligrams) or active placebo doses (30 milligrams).
2. 03:08 PM
From emergence to eruption: Comprehensive model captures life of a solar flare
3. 03:00 PM
Drones shown to make traffic crash site assessments safer, faster and more accurate
4. 02:44 PM
Scientists identify two new species of fungi in retreating Arctic glacier